Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
- DOI
- 10.1002/alz.12651
- Published
- 2023 Jan
- Container
- Alzheimer's & dementia : the journal of the Alzheimer's Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.12651,
title = {Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.},
author = {Brody M and Agronin M and Herskowitz BJ and Bookheimer SY and Small GW and Hitchinson B and Ramdas K and Wishard T and McInerney KF and Vellas B and Sierra F and Jiang Z and Mcclain-Moss L and Perez C and Fuquay A and Rodriguez S and Hare JM and Oliva AA Jr and Baumel B},
year = {2023},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
doi = {10.1002/alz.12651},
url = {https://doi.org/10.1002/alz.12651}
}RIS
TY - JOUR TI - Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease. AU - Brody M AU - Agronin M AU - Herskowitz BJ AU - Bookheimer SY AU - Small GW AU - Hitchinson B AU - Ramdas K AU - Wishard T AU - McInerney KF AU - Vellas B AU - Sierra F AU - Jiang Z AU - Mcclain-Moss L AU - Perez C AU - Fuquay A AU - Rodriguez S AU - Hare JM AU - Oliva AA Jr AU - Baumel B PY - 2023 JO - Alzheimer's & dementia : the journal of the Alzheimer's Association DO - 10.1002/alz.12651 UR - https://doi.org/10.1002/alz.12651 ER -
APA
M, B., M, A., BJ, H., SY, B., GW, S., B, H., K, R., T, W., KF, M., B, V., F, S., Z, J., L, M., C, P., A, F., S, R., JM, H., Jr, O. A., & B, B. (2023). Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.12651
Source records
- pubmed · retrieved 2026-09-25T02:07:11.378Z